Lymphangiosarcoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 42: Line 42:
[[Lymphangiosarcoma medical therapy|Medical Therapy]] | [[Lymphangiosarcoma surgery|Surgery]] | [[Lymphangiosarcoma primary prevention|Primary Prevention]] | [[Lymphangiosarcoma secondary prevention|Secondary Prevention]] | [[Lymphangiosarcoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lymphangiosarcoma future or investigational therapies|Future or Investigational Therapies]]
[[Lymphangiosarcoma medical therapy|Medical Therapy]] | [[Lymphangiosarcoma surgery|Surgery]] | [[Lymphangiosarcoma primary prevention|Primary Prevention]] | [[Lymphangiosarcoma secondary prevention|Secondary Prevention]] | [[Lymphangiosarcoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lymphangiosarcoma future or investigational therapies|Future or Investigational Therapies]]


==Related chapters==
==Related Chapters==
* [[Lymphangioma]]
* [[Lymphangioma]]



Revision as of 14:19, 11 September 2012

For patient information, click here

Template:DiseaseDisorder infobox Template:Lymphangiosarcoma Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes of Lymphangiosarcoma

Differentiating Lymphangiosarcoma from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms | Physical Examination | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Related Chapters


Template:WikiDoc Sources